Skip to main content
. 2022 Dec 27;15(1):154. doi: 10.3390/cancers15010154

Figure 3.

Figure 3

(a) Frequency of CA in 30 primary B-ALL samples and six primary bone marrow stem cell samples. (mean ± SD, >20 cells per bar). (b) Frequency of CA in 4 cell lines, 30 primary B-ALL samples, and 6 primary bone marrow stem cell samples. (mean ± SD, p = <0.0001, One-way ANOVA). (c) Frequency of CA in primary B-ALL samples comparing karyotype (euploid and aneuploid), risk level (average, high, very high), sex (male and female), and stage (initial diagnosis (Dx) and relapse (Rel)). (mean ± SD, ns = not significant, One-way ANOVA, p-value indicated on graph).